Assess Aesthetic Improvement With QM1114-DP in Subjects With Moderate to Severe Lateral Canthal Lines and Glabellar Lines

Open-label Study to Assess Aesthetic Improvement Following Treatment With QM1114-DP in Subjects With Moderate to Severe Lateral Canthal Lines and Glabellar Lines

This study to assess aesthetic improvement following treatment with QM1114-DP.

This was an open-label, single-center multi-center study to assess aesthetic improvement in the Glabellar and Lateral Canthal regions following treatment with QM1114-DP.

Inclusion Criteria:

• Male or Female 18 years or older
• Moderate to severe bilaterally symmetrical LCL as assessed by the investigator
• Moderate to severe GL at maximum frown as assessed by the Investigator

Exclusion Criteria:

• Previous use of any botulinum toxin in facial areas within 9 months prior to study treatment
• Female who was pregnant, breast feeding or intended to conceive a child during the study.
• Known allergy to hypersensitivity or any component of the Investigational product